FR17C1011I2 - PROTEASOME INHIBITORS - Google Patents

PROTEASOME INHIBITORS

Info

Publication number: FR17C1011I2
Authority: FR; France
Prior art keywords: proteasome inhibitors; proteasome; inhibitors
Prior art date: 2007-08-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR17C1011C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Millennium Pharmaceuticals Inc

Original Assignee

Millennium Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-06

Filing date

2017-04-14

Publication date

2018-04-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38691782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR17C1011(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-04-14 Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc

2017-05-26 Publication of FR17C1011I1 publication Critical patent/FR17C1011I1/fr

2018-04-27 Application granted granted Critical

2018-04-27 Publication of FR17C1011I2 publication Critical patent/FR17C1011I2/en

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FR17C1011C 2007-08-06 2017-04-14 PROTEASOME INHIBITORS Active FR17C1011I2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2007/017440 WO2009020448A1 (en)	2007-08-06	2007-08-06	Proteasome inhibitors

Publications (2)

Publication Number	Publication Date
FR17C1011I1 FR17C1011I1 (en)	2017-05-26
FR17C1011I2 true FR17C1011I2 (en)	2018-04-27

Family

ID=38691782

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR17C1011C Active FR17C1011I2 (en)	2007-08-06	2017-04-14	PROTEASOME INHIBITORS

Country Status (32)

Country	Link
EP (3)	EP2178888B1 (en)
JP (1)	JP5261488B2 (en)
KR (6)	KR20160040735A (en)
CN (1)	CN101772507B (en)
AU (1)	AU2007357338B2 (en)
BR (1)	BRPI0721905B8 (en)
CA (1)	CA2695082C (en)
CY (2)	CY1113386T1 (en)
DK (1)	DK2178888T3 (en)
EA (1)	EA028622B1 (en)
EC (1)	ECSP10010015A (en)
ES (1)	ES2390606T3 (en)
FR (1)	FR17C1011I2 (en)
GE (1)	GEP20125599B (en)
HR (1)	HRP20120745T1 (en)
HU (1)	HUS1700018I1 (en)
IL (4)	IL203641A (en)
LT (1)	LTC2178888I2 (en)
LU (1)	LUC00013I2 (en)
MY (1)	MY161991A (en)
NL (1)	NL300871I2 (en)
NZ (1)	NZ582693A (en)
PH (1)	PH12014500053B1 (en)
PL (1)	PL2178888T3 (en)
PT (1)	PT2178888E (en)
RS (1)	RS52435B (en)
SG (1)	SG10201508712QA (en)
SI (1)	SI2178888T1 (en)
TN (1)	TN2010000060A1 (en)
UA (1)	UA97536C2 (en)
WO (1)	WO2009020448A1 (en)
ZA (1)	ZA201000348B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7576206B2 (en)	2003-08-14	2009-08-18	Cephalon, Inc.	Proteasome inhibitors and methods of using the same
US7468383B2 (en)	2005-02-11	2008-12-23	Cephalon, Inc.	Proteasome inhibitors and methods of using the same
JP5436860B2 (en)	2005-11-09	2014-03-05	オニキスセラピューティクス，インク．	Compounds for enzyme inhibition
WO2007149512A2 (en)	2006-06-19	2007-12-27	Proteolix, Inc.	Peptide epoxyketones for pr0teas0me inhibition
US7442830B1 (en)	2007-08-06	2008-10-28	Millenium Pharmaceuticals, Inc.	Proteasome inhibitors
MY173938A (en)	2007-10-04	2020-02-27	Onyx Therapeutics Inc	Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
PT2730581T (en)	2008-06-17	2016-08-17	Millennium Pharm Inc	Boronate ester compounds and pharmaceutical compositions thereof
AR075090A1 (en)	2008-09-29	2011-03-09	Millennium Pharm Inc	ACID DERIVATIVES 1-AMINO-2-CYCLLOBUTILETILBORONICO PROTEOSOMA INHIBITORS, USEFUL AS ANTI-BANKER AGENTS, AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM.
AU2009308516B2 (en)	2008-10-21	2016-08-25	Onyx Therapeutics, Inc.	Combination therapy with peptide epoxyketones
AR075899A1 (en)	2009-03-20	2011-05-04	Onyx Therapeutics Inc	PROTEASA INHIBITING CRYSTALLINE EPOXYCETON TRIPEPTIDES
US8853147B2 (en)	2009-11-13	2014-10-07	Onyx Therapeutics, Inc.	Use of peptide epoxyketones for metastasis suppression
CA2785300A1 (en)	2009-12-22	2011-07-21	Cephalon, Inc.	Proteasome inhibitors and processes for their preparation, purification and use
BR112012022060A2 (en)	2010-03-01	2018-05-08	Onyx Therapeutics Inc	compound for inhibition of immunoproteasome
MX2012011298A (en)	2010-03-31	2012-11-06	Millennium Pharm Inc	Derivatives of 1-amino-2-cyclopropylethylboronic acid.
CA2833775A1 (en) *	2011-06-22	2012-12-27	Cephalon, Inc.	Proteasome inhibitors and processes for their preparation, purification and use
CN108383893A (en) *	2011-08-30	2018-08-10	塔夫茨大学信托人	The proteasome inhibitor that FAP- for treating solid tumor is activated
EA201400735A1 (en) *	2011-12-22	2015-04-30	Арес Трейдинг С.А.	DERIVATIVES ALPHA-AMINO BORONIC ACID, SELECTIVE INHIBITORS IMMUNOPROTEASOMA
EP2812338A4 (en) *	2012-01-24	2015-09-23	Millennium Pharm Inc	METHOD OF TREATING NASOPHARYNGEAL CANCER
EP2810066B1 (en) *	2012-01-24	2019-07-31	Millennium Pharmaceuticals, Inc.	Methods of treatment of cancer
US20140105921A1 (en)	2012-07-09	2014-04-17	Onyx Therapeutics, Inc.	Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
CN103570806B (en) *	2012-07-26	2020-04-07	圣特莱国际公司	Polypeptide epoxy ketone compound
JP2013006855A (en) *	2012-09-03	2013-01-10	Millennium Pharmaceuticals Inc	Proteasome inhibitor
JP6018319B2 (en) *	2012-12-03	2016-11-02	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	Substituted triazole boronic acid compounds
US20160250238A1 (en) *	2013-10-03	2016-09-01	Millennium Pharmaceuticals, Inc.	Method for the Prophylaxis or Treatment of Systemic Lupus Erythematosus and/or Lupus Nephritis
US20150335668A1 (en)	2014-05-20	2015-11-26	Millennium Pharmaceuticals, Inc.	Method for cancer therapy
EP3177292B1 (en)	2014-08-07	2020-11-25	Mayo Foundation for Medical Education and Research	Compounds and methods for treating cancer
MA41555A (en) *	2015-02-17	2017-12-26	Millennium Pharm Inc	POLYTHERAPY FOR CANCER TREATMENT
WO2016205790A2 (en)	2015-06-19	2016-12-22	Hanlin Scientific, Inc.	Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
CN106608883A (en) *	2015-10-21	2017-05-03	北京大学	Synthetic method of proteasome inhibitor MLN9708
WO2017198194A1 (en) *	2016-05-19	2017-11-23	成都奥璟生物科技有限公司	Boronic acid and borate ester compound and applications thereof
CN106008572B (en) *	2016-05-23	2018-08-17	成都千禧莱医药科技有限公司	A kind of dipeptide boronic acid compound and preparation method and purposes
EP3472151A4 (en)	2016-06-21	2020-03-04	Orion Ophthalmology LLC	CARBOCYCLIC PROLINAMIDE DERIVATIVES
JP7179721B2 (en)	2016-06-21	2022-11-29	オリオン・オフサルモロジー・エルエルシー	Heterocyclic prolinamide derivative
WO2018019196A1 (en) *	2016-07-25	2018-02-01	深圳市塔吉瑞生物医药有限公司	Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof
CN108440583B (en) *	2017-01-23	2020-12-04	成都奥璟生物科技有限公司	Boric acid derivative and its medicinal composition
US11596629B2 (en)	2017-02-28	2023-03-07	Mayo Foundation For Medical Education And Research	Compounds and methods for treating cancer
CN108794516A (en) *	2017-04-26	2018-11-13	上海时莱生物技术有限公司	Boric acid and boric acid ester compound and its preparation method and application
CN109305980B (en) *	2017-07-28	2022-10-11	成都奥璟生物科技有限公司	Borate compound, and synthesis method and application thereof
ES2901022T3 (en)	2017-08-25	2022-03-21	Synthon Bv	Procedure for the preparation of ixazomib and its intermediates
JP2018024694A (en) *	2017-10-03	2018-02-15	ミレニアムファーマシューティカルズ，インコーポレイテッドＭｉｌｌｅｎｎｉｕｍＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ．	Proteasome inhibitor
US11243207B2 (en)	2018-03-29	2022-02-08	Mayo Foundation For Medical Education And Research	Assessing and treating cancer
CN115403603A (en) *	2018-09-14	2022-11-29	成都奥璟生物科技有限公司	Boric acid ester medicine and application thereof
CN110357787A (en) *	2019-08-02	2019-10-22	苏州艾和医药科技有限公司	Yi Shazuo meter synthesising process research
US20220362268A1 (en) *	2019-10-07	2022-11-17	Cornell University	Antimicrobial and antiviral effects of c2-c7 alkyl boronic acids
CN110950897B (en) *	2019-12-12	2021-05-28	山东大学	A kind of histone deacetylase, proteasome dual-target inhibitor and preparation method and application thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4499082A (en)	1983-12-05	1985-02-12	E. I. Du Pont De Nemours And Company	α-Aminoboronic acid peptides
US5187157A (en)	1987-06-05	1993-02-16	Du Pont Merck Pharmaceutical Company	Peptide boronic acid inhibitors of trypsin-like proteases
US5250720A (en)	1987-06-05	1993-10-05	The Dupont Merck Pharmaceutical Company	Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en)	1987-06-05	1993-09-07	The Dupont Merck Pharmaceutical Company	Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (en)	1987-11-05	1990-08-22	Hoechst Aktiengesellschaft	Renin inhibitors
US5106948A (en)	1988-05-27	1992-04-21	Mao Foundation For Medical Education And Research	Cytotoxic boronic acid peptide analogs
US6083903A (en) *	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
EP2251344B2 (en)	2001-01-25	2024-04-24	THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Formulation of boronic acid compounds
ATE317850T1 (en)	2001-05-30	2006-03-15	Novartis Pharma Gmbh	2-((N-(2-AMINO-3-(HETEROARYL- OR - ARYL)PROPIONYL)AMINOACYL)AMINO)- ALKYLBORONIC ACID DERIVATIVES
UA88771C2 (en) *	2003-08-14	2009-11-25	Сефалон, Инк.	Proteasome inhibitors and methods of using the same (variants)
US7223745B2 (en)	2003-08-14	2007-05-29	Cephalon, Inc.	Proteasome inhibitors and methods of using the same
US7576206B2 (en)	2003-08-14	2009-08-18	Cephalon, Inc.	Proteasome inhibitors and methods of using the same
WO2005097809A2 (en) *	2004-03-30	2005-10-20	Millennium Pharmaceuticals, Inc.	Synthesis of boronic ester and acid compounds
WO2006008660A2 (en)	2004-07-20	2006-01-26	Affinium Pharmaceuticals, Inc.	Streptococcus pneumoniae enoyl- (acyl-carrier-protein) reductase (fabk)
TW200618820A (en) *	2004-11-05	2006-06-16	Alza Corp	Liposome formulations of boronic acid compounds
GB0513349D0 (en)	2005-06-29	2005-08-03	Torres Manel	Non-woven fabric
CN101247799B (en)	2005-07-05	2013-03-27	塔夫茨大学信托人	Inhibitors of fibroblast activation protein alpha

2007
- 2007-08-06 EA EA201070247A patent/EA028622B1/en not_active IP Right Cessation
- 2007-08-06 EP EP07811087A patent/EP2178888B1/en active Active
- 2007-08-06 RS RS20120405A patent/RS52435B/en unknown
- 2007-08-06 KR KR1020167008358A patent/KR20160040735A/en not_active Ceased
- 2007-08-06 EP EP16201780.0A patent/EP3210987A1/en active Pending
- 2007-08-06 EP EP12171220A patent/EP2527347A1/en not_active Withdrawn
- 2007-08-06 KR KR1020147007078A patent/KR20140042933A/en not_active Abandoned
- 2007-08-06 KR KR1020147007077A patent/KR20140042932A/en not_active Ceased
- 2007-08-06 KR KR1020167036758A patent/KR101831674B1/en active Active
- 2007-08-06 MY MYPI2010000270A patent/MY161991A/en unknown
- 2007-08-06 PT PT07811087T patent/PT2178888E/en unknown
- 2007-08-06 HR HRP20120745TT patent/HRP20120745T1/en unknown
- 2007-08-06 KR KR1020107003809A patent/KR101474831B1/en active Active
- 2007-08-06 ES ES07811087T patent/ES2390606T3/en active Active
- 2007-08-06 SI SI200731030T patent/SI2178888T1/en unknown
- 2007-08-06 UA UAA201002409A patent/UA97536C2/en unknown
- 2007-08-06 CN CN2007801001423A patent/CN101772507B/en active Active
- 2007-08-06 BR BRPI0721905A patent/BRPI0721905B8/en active IP Right Grant
- 2007-08-06 AU AU2007357338A patent/AU2007357338B2/en active Active
- 2007-08-06 JP JP2010519898A patent/JP5261488B2/en active Active
- 2007-08-06 PL PL07811087T patent/PL2178888T3/en unknown
- 2007-08-06 CA CA2695082A patent/CA2695082C/en active Active
- 2007-08-06 NZ NZ582693A patent/NZ582693A/en unknown
- 2007-08-06 SG SG10201508712QA patent/SG10201508712QA/en unknown
- 2007-08-06 WO PCT/US2007/017440 patent/WO2009020448A1/en not_active Ceased
- 2007-08-06 KR KR1020157000064A patent/KR20150010802A/en not_active Ceased
- 2007-08-06 GE GEAP200711714A patent/GEP20125599B/en unknown
- 2007-08-06 DK DK07811087.1T patent/DK2178888T3/en active
2010
- 2010-01-18 ZA ZA2010/00348A patent/ZA201000348B/en unknown
- 2010-02-01 IL IL203641A patent/IL203641A/en active Protection Beyond IP Right Term
- 2010-02-05 TN TNP2010000060A patent/TN2010000060A1/en unknown
- 2010-03-04 EC EC2010010015A patent/ECSP10010015A/en unknown
2012
- 2012-09-17 CY CY20121100845T patent/CY1113386T1/en unknown
2014
- 2014-01-06 PH PH12014500053A patent/PH12014500053B1/en unknown
2015
- 2015-10-26 IL IL242292A patent/IL242292A/en active IP Right Grant
- 2015-10-26 IL IL242290A patent/IL242290A/en active IP Right Grant
- 2015-10-26 IL IL242291A patent/IL242291A/en active IP Right Grant
2017
- 2017-04-05 LU LU00013C patent/LUC00013I2/fr unknown
- 2017-04-06 LT LTPA2017010C patent/LTC2178888I2/en unknown
- 2017-04-14 FR FR17C1011C patent/FR17C1011I2/en active Active
- 2017-04-26 CY CY2017016C patent/CY2017016I2/en unknown
- 2017-05-03 HU HUS1700018C patent/HUS1700018I1/en unknown
- 2017-05-05 NL NL300871C patent/NL300871I2/en unknown

Also Published As

Publication number	Publication date
CY1113386T1 (en)	2016-06-22
EA201070247A1 (en)	2010-06-30
CA2695082A1 (en)	2009-02-12
CY2017016I1 (en)	2017-07-12
LUC00013I2 (en)	2017-06-19
SG10201508712QA (en)	2015-11-27
KR20150010802A (en)	2015-01-28
EP2527347A1 (en)	2012-11-28
IL242290A0 (en)	2015-11-30
SI2178888T1 (en)	2012-11-30
KR20160040735A (en)	2016-04-14
KR20140042932A (en)	2014-04-07
LUC00013I1 (en)	2017-04-06
BRPI0721905A2 (en)	2014-02-25
FR17C1011I1 (en)	2017-05-26
ES2390606T3 (en)	2012-11-14
BRPI0721905B8 (en)	2021-05-25
IL242292A0 (en)	2015-11-30
IL242291A0 (en)	2015-11-30
HUS1700018I1 (en)	2017-05-29
KR101831674B1 (en)	2018-02-23
EP3210987A1 (en)	2017-08-30
LTC2178888I2 (en)	2018-03-12
ECSP10010015A (en)	2010-04-30
KR101474831B1 (en)	2014-12-19
CA2695082C (en)	2015-07-28
LTPA2017010I1 (en)	2017-05-10
HK1182924A1 (en)	2013-12-13
EP2178888B1 (en)	2012-07-04
NZ582693A (en)	2012-01-12
IL242290A (en)	2017-12-31
PH12014500053A1 (en)	2015-03-30
HRP20120745T1 (en)	2012-10-31
IL242292A (en)	2017-12-31
RS52435B (en)	2013-02-28
JP2010535759A (en)	2010-11-25
WO2009020448A1 (en)	2009-02-12
PT2178888E (en)	2012-10-04
BRPI0721905B1 (en)	2020-11-17
IL203641A (en)	2015-11-30
KR20170004031A (en)	2017-01-10
ZA201000348B (en)	2011-03-30
CN101772507B (en)	2012-12-12
PH12014500053B1 (en)	2015-03-30
IL242291A (en)	2017-12-31
CN101772507A (en)	2010-07-07
KR20100059811A (en)	2010-06-04
AU2007357338B2 (en)	2014-03-20
CY2017016I2 (en)	2017-07-12
TN2010000060A1 (en)	2011-09-26
EP2178888A1 (en)	2010-04-28
DK2178888T3 (en)	2012-10-01
JP5261488B2 (en)	2013-08-14
NL300871I2 (en)	2017-12-07
HK1143595A1 (en)	2011-01-07
EA028622B1 (en)	2017-12-29
KR20140042933A (en)	2014-04-07
GEP20125599B (en)	2012-08-10
PL2178888T3 (en)	2012-11-30
UA97536C2 (en)	2012-02-27
MY161991A (en)	2017-05-31
AU2007357338A1 (en)	2009-02-12

Publication	Publication Date	Title
FR17C1011I2 (en)	2018-04-27	PROTEASOME INHIBITORS
CY2020023I2 (en)	2020-11-25	BETA-LACTAMAS INHIBITORS
BRPI0807547A2 (en)	2014-06-17	HYPERCYCLIC ASPARTIL PROTEASE INHIBITORS
CR10831A (en)	2009-06-18	ESPIRO KETONA ACETIL-CoA CARBOXILASA INHIBITORS
BRPI0814797A2 (en)	2015-02-03	DNA-PK INHIBITORS
DK2041138T3 (en)	2014-08-11	PYRROLTRIAZINKINASE INHIBITORS
DK2024375T3 (en)	2011-06-27	Cyclopropyl-condensed indolobenzazepine-HCV-NS5B inhibitors
IT1394247B1 (en)	2012-06-01	TIGHTENING DEVICE
BRPI0810365A2 (en)	2014-10-29	INDOL 7-REPLACED MLC-1 INHIBITORS
EP2305306A4 (en)	2012-08-29	NEURO-INVASION INHIBITOR
BRPI0918564A2 (en)	2015-12-01	inhibitors
BRPI0807772A2 (en)	2014-06-24	PACKING DEVICE
BRPI0912234A2 (en)	2015-10-06	salinosporamide derivatives as proteasome inhibitors
AT506380A3 (en)	2010-02-15	STAMP DEVICE
DE602009001221D1 (en)	2011-06-16	sealing device
DK2066662T3 (en)	2013-01-07	SERINHYDROLASE INHIBITORS
EP2435048A4 (en)	2013-07-10	RADIO-MARKED PDE10 INHIBITORS
BRPI0918966A2 (en)	2015-12-01	protease inhibitors
NO20070960A (en)	2008-06-02	Teine
BRPI0919073A2 (en)	2016-03-15	protease inhibitors
FI20075320A0 (en)	2007-05-07	New useful inhibitors
FI20075579L (en)	2009-02-18	Holding device
GB0707315D0 (en)	2007-05-23	Novel proteasome inhibitor
ITMI20061754A1 (en)	2008-03-15	PERFORMED BEVELING DEVICE